Additional Analysis 1
Summary of Estimated Patients 1
Additional Analysis 2
TAG CER for Fremanezumab
Summary of Estimated Patients 3
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
FOI release date:
This request summaries and commentary about the pre-PBAC evaluation of AJOVY (fremanezumab)